InsideArbitrage Event Driven Monitor – May 13, 2024

  • May 13, 2024
Merger Arbitrage OLK: The UK’s Competition and Markets Authority (CMA) launched its merger inquiry for the acquisition of Olink Holding (OLK) by Thermo Fisher Scientific (TMO). ALPN: Alpine Immune Sciences, Inc. (ALPN) announced that Alpine and Vertex (VRTX) had filed the respective Premerger Notification and Report Forms with the FTC and the Antitrust Division on April 24, 2024, and the required waiting period under the HSR Act for the merger expired on May 9, 2024. FUSN: Fusion Pharmaceuticals (FUSN) cleared the initial 45-day review period under the Investment Canada Act on May 9, 2024, without receipt of a notice, thus satisfying the condition for its merger with AstraZeneca (AZN). WIRE: Encore Wire (WIRE) filed the preliminary proxy statement for its merger with Prysmian. MODN: According to Bloomberg, a group of private credit lenders led by Oak Hill Advisors is in discussions to provide about $1 billion of debt to support Vista Equity Partners’ acquisition of Model N (MODN). AIRC: Apartment Income REIT Corp. (AIRC) filed the preliminary proxy statement for its merger with Blackstone Inc (BX). MOR: Novartis (NVS) announced that the acceptance of the takeover offer to purchase all no-par value registered shares of MorphoSys (MOR) has been validly declared. HES: U.S. Senate Majority Leader Chuck Schumer urged the Federal Trade Commission...

Only plus or premium subscribers can access this post. Subscribe today.